fbpx
NOTICE: This website and other PSA services will undergo maintenance between 08:00AM and 11:59AM AEST on Sunday May 12th 2024.
Click here for more information.

Pharmacists can deliver on current and future challenges

25 August 2023

 

Following the release of the Australian Government’s Intergenerational Report 2023, the Pharmaceutical Society of Australia (PSA) has called for pharmacists to be able to do more to support the country’s increased healthcare needs as our population ages.

 

The report, released yesterday, highlights five major factors affecting public policy moving forward. In particular, the report acknowledges that Australia’s ageing population and rising demand for care and support services will add further pressure on our already strained health system, hospital emergency departments, and further exacerbate wait times in General Practice.

 

PSA National President Dr Fei Sim FPS said the report highlighted both the urgent and the long-term need for pharmacists in all practice areas to work to their top of scope.

 

“The Federal Government’s Intergenerational Report confirmed that our gaining population will continue to have a significant impact on the Australian economy,” she said.

 

“Combined with the rising demand for quality health care services, we must be able to ensure the long-term sustainability of our health system.

 

“Access to care is a growing issue in Australia, and the situation is exacerbated in rural and remote communities.

 

“Australians need all health professionals working to their top of scope – including pharmacists.”

 

The Federal Government also announced yesterday that ANU’s Professor Mark Cormack will lead the Unleashing the Potential of our Health Workforce Review, to be delivered in 2024.

 

“The government’s scope of practice review needs to heed the warnings of the Intergenerational report and unlock the potential of our health workforce using pharmacists,” Dr Sim said.

 

“Pharmacists are highly trained health professionals and should be supported to practise to full scope, contributing to sustainability of our health system to enable equitable access to healthcare by all Australians.

 

“There are a range of common ailments which can be safely and effectively managed by pharmacists, supported by international evidence, facilitating safe and timely care.

 

“This can only be achieved with meaningful investment and funding to empower pharmacists to deliver important health care to Australians.

 

“Pharmacists can, and should, play a significant role to improve Australian’s access to care, and contribute towards quality, safe and effective use of medicines in all parts of the healthcare system.

 

“On behalf of Australian pharmacists, I look forward to working with Professor Cormack and his team on the Unleashing the Potential of our Health Workforce Review,” Dr Sim concluded.

 

The Federal Government’s Intergenerational Report is available here.

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

8CPA negotiations to begin a year ahead of schedule

8 August 2023

 

The PSA welcomes the Federal Government’s announcement that early negotiations for the 8th Community Pharmacy Agreement (CPA) will begin as soon as possible, whilst highlighting the need to secure the short-term viability of the community pharmacy sector.

 

Federal Minister for Health and Aged Care Mark Butler MP has said the Pharmaceutical Society of Australia (PSA) and the Pharmacy Guild of Australia will continue to be signatories to any new agreement, with negotiations set to conclude by the end of the 2023-24 financial year.

 

PSA National President Dr Fei Sim FPS said that negotiations for 8CPA must harness community pharmacists as the solution to Australia’s primary care crisis – but emphasised immediate and long-term viability risks could make this difficult to achieve.

 

“PSA looks forward to working with the government and the Pharmacy Guild to drive better and safer access to medicines for Australians,” Dr Sim said.

 

“We need to do more to reduce the preventable harm medicines are causing in Australia. Up to half of the 250,000 medicine-related hospital admissions per year in Australia are preventable.

 

“More Australians are finding it more difficult to access their essential medicines due to waiting times to access their regular prescribers. These are real problems PSA will seek solutions for during the 8CPA negotiations.

 

“The new agreement should enable pharmacists to practice to full scope. This agreement should deliver better access to care for all Australians by cementing the core role of pharmacists as the stewards for safe and effective use of medicines.”

 

“As the peak body representing pharmacists in Australia, and as steward of professional standards, PSA is committed to working constructively and collaboratively during this process of negotiation to deliver the outcome which includes better ways for pharmacists to show the impact of the care they provide.

 

“PSA has championed embedding of quality and safety measures in pharmacy programs for many years, and will seek to drive evaluation measures in CPA programs to help demonstrate the role pharmacists play every day in supporting safer and more effective use of medicines.

 

“While there is up to 11 months before negotiations are proposed to conclude, the real impact of 60-day dispensing will be felt immediately by community pharmacists as the measure commences on 1 September. We must ensure close alignment between the commencement of 60-day dispensing and the commencement of a new community pharmacy agreement.

 

“Pharmacists need certainty now that the care they provide will remain viable in the short term.

 

“As a profession, pharmacists can do more and want to do more. But we can’t keep doing more with less.”

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au